great result stockrock with both primary end points met. was also very pleased with the results for the secondary endpoints as these positively impact patient perception of treatment and prevention. looks like a very promising second half for SPL.
- Forums
- ASX - By Stock
- FDA Phase 3 passed!! Amazing!!
great result stockrock with both primary end points met. was...
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.90M |
Open | High | Low | Value | Volume |
10.5¢ | 11.5¢ | 10.0¢ | $110.6K | 1.006M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 83046 | 10.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.0¢ | 30000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 83046 | 0.105 |
3 | 198569 | 0.100 |
1 | 10111 | 0.099 |
3 | 483557 | 0.096 |
1 | 824859 | 0.095 |
Price($) | Vol. | No. |
---|---|---|
0.110 | 30000 | 1 |
0.115 | 122753 | 4 |
0.120 | 221197 | 6 |
0.125 | 30000 | 1 |
0.130 | 138570 | 2 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online